Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Gabalex Capital’s Top Stock Picks For Q4

Page 1 of 2

Gabalex Capital is a New York-based long/short equity hedge fund established by Nigel Greig and Kenneth Cowin in 2008. Prior to founding Gabalex Capital, Mr. Greig worked at the now defunct investment banking giant Bear Stearns for over a decade. While Mr. Cowin serves as the COO, Mr. Greig heads the fund and is also its largest shareholder. As of January 2015, Gabalex Capital managed almost $400 million of investors’ money. The fund recently submitted its 13F filing with the SEC for the reporting quarter ending September 30. According to the filing, Gabalex Capital’s US equity portfolio at the end of September was worth nearly $257 million, $21.17 million less than what it was worth at the end of June. By taking a closer look at the filing one can conclude that Gabalex Capital runs a fairly concentrated portfolio by hedge fund standards with open positions in just 22 stocks and its top 10 holdings accounting for 83.06% value of its equity portfolio. Research done by Insider Monkey over the years shows that generally hedge funds which run a highly concentrated portfolio put a special emphasis on thoroughly studying a stock before buying it and hence those stock picks have a slight edge over other stocks when it comes to performance. Taking this into account, in this article we will be analyzing Gabalex Capital’s top five stock picks from the end of the third quarter and try to figure out why the fund is betting big on these companies.

Alleghany Technologies ATI

We track hedge funds and prominent investors because our research has shown that historically their stock picks delivered superior risk-adjusted returns. This is especially true in the small-cap space. The 50 most popular large-cap stocks among hedge funds had a monthly alpha of about 6 basis points per month between 1999 and 2012; however the 15 most popular small-cap stocks delivered a monthly alpha of 80 basis points during the same period. This means investors would have generated 10 percentage points of alpha per year simply by imitating hedge funds’ top 15 small-cap ideas. We have been tracking the performance of these stocks since the end of August 2012 in real time and these stocks beat the market by 53 percentage points (102 % return vs. S&P 500’s 49% gain) over the last 37 months (see the details here).

Adam Usdan
Adam Usdan
Trellus Management Company

#5 Priceline Group Inc (NASDAQ:PCLN)

Shares Owned by Gabalex Capital (as of September 30): 15,000 shares

Value of Holding (as of September 30): $18.553 Million

Gabalex Capital reduced its stake by 25% or 5,000 shares in online travel and reservation services provider Priceline Group Inc (NASDAQ:PCLN) during the third quarter. Owing largely  to the decent surge they saw in February and more recently during October, shares of the company are trading up 27.16% year-to-date. The announcement by the company in October that it will be forming a strategic partnership with TripAdvisor was a major contributor to the rise that its stock saw during that period. Priceline Group Inc (NASDAQ:PCLN) is scheduled to report its fiscal 2015 third quarter results on November 9 and the expectations among analysts include EPS of $24.23 on revenue of $3.05 billion, above the EPS of $21.11 on revenue of $2.84 billion it reported for the same quarter last year. Stephen Mandel’s Lone Pine Capital holds Priceline among its top picks,  according to its latest investor letter (see article).

Follow Priceline Group Inc. (NASDAQ:PCLN)
Trade (NASDAQ:PCLN) Now!

#4 Berkshire Hathaway Inc. (NYSE:BRK.B)

Shares Owned by Gabalex Capital (as of September 30): 150,000 shares

Value of Holding (as of September 30): $19.56 Million

Though Gabalex Capital didn’t make any changes to its stake in Berkshire Hathaway Inc. (NYSE:BRK.B) during the third quarter, the 4.19% decline that the company’s shares suffered during that period meant that the value of Gabalex Capital’s holding also inched down. Shares of Berkshire Hathaway Inc. (NYSE:BRK.B) have suffered a gradual decline throughout 2015 and even the bounce they saw during October hasn’t provided much of a respite as they trade with year-to-date loss of 9.2%. On November 6, the company declared its fiscal 2015 third quarter earnings. Operating earnings for the quarter came in-line with Street’s expectations of $1.85 per class B share, but revenue at $58.99 billion was lower than the $61.12 billion figure the Street had expected. Whitney Tilson of Kase Capital has reiterated his bullish position on Berkshire in the latest letter to investors, saying that the stock is trading considerably below its intrinsic value.

Follow Berkshire Hathaway Inc (NYSE:BRK.A)
Trade (NYSE:BRK.A) Now!

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!